Siemens Healthineers Hemoglobin A1c Test on Atellica Solution
Siemens Healthineers announced the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes.
The firm said that demands will continue to grow on laboratories for screening and monitoring as the diabetic population continues to expand. It noted that instruments with higher throughput capabilities offer laboratories the ability to run a greater volume of tests and produce patient results more quickly, and laboratories are seeking HbA1c assays that can be integrated onto chemistry testing platforms. The Atellica CH Enzymatic Hemoglobin A1c Assay offers these capabilities, Siemens said.